Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Sulforaphane, Lycopene, And Beta Carotenoid And Uses Thereof

Abstract: The present disclosure relates to a composition comprising antioxidant species for enhanced inhibition of intracellular reactive oxygen species (ROS) production. The disclosure also provides a method for the same, and formulations for oral ingestion or cosmetic application for inhibition of ROS production.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
11 April 2014
Publication Number
01/2016
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
lsmds@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2022-12-20
Renewal Date

Applicants

ITC LIMITED
ITC-LIFE SCIENCE AND TECHNOLOGY CENTER #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Inventors

1. SHETTY, Shilpa
ITC Life Science and Technology Center #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058,
2. KS, Nandakumar
ITC Life Science and Technology Center #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058
3. FATIMA, Humaira
ITC Life Science and Technology Center #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058
4. CHITTUR, Lakshmanan Chandrasekharan
ITC Life Science and Technology Center #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Specification

CLIAMS:1. A composition comprising:
a. sulforaphane;
b. lycopene; and
c. beta-carotene,
wherein said composition inhibits intracellular reactive oxygen species (ROS) production.
2. The composition as claimed in claim 1, wherein the w/w ratio of beta-carotene:lycopene is 4:1.
3. The composition as claimed in claim 1, wherein the w/w ratio of sulforaphane:beta-carotene and lycopene is in the range of approximately 1:14-1:230.
4. The composition as claimed in claim 1, wherein the w/w ratio of sulforaphane:beta-carotene and lycopene is in the range of approximately 1:30-1:70.
5. The composition as claimed in claim 1, wherein the w/w ratio of sulforaphane:beta-carotene and lycopene is approximately 1:40.
6. A method of inhibiting intracellular reactive oxygen species (ROS) production, said method comprising:
a. obtaining a composition as claimed in claim 1; and
b. contacting the composition from (a) with a host.
7. A formulation for oral ingestion comprising a composition as claimed in claim 1.
8. A formulation for cosmetic application comprising a composition as claimed in claim 1.
9. The formulation as claimed in claim 8 or 9, wherein said formulation further comprises suitable diluents, carriers, and excipients.
Dated this 11th day of April 2014
,TagSPECI:As Attached

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 1935-CHE-2014-IntimationOfGrant20-12-2022.pdf 2022-12-20
1 SPEC FOR FILING.pdf 2014-06-02
2 FORM 5.pdf 2014-06-02
2 1935-CHE-2014-PatentCertificate20-12-2022.pdf 2022-12-20
3 FORM 3.pdf 2014-06-02
3 1935-CHE-2014-Written submissions and relevant documents [04-05-2022(online)].pdf 2022-05-04
4 FIGURES FOR FILING.pdf 2014-06-02
4 1935-CHE-2014-Correspondence to notify the Controller [15-04-2022(online)].pdf 2022-04-15
5 1935-CHE-2014-FORM-26 [11-04-2022(online)].pdf 2022-04-11
5 1935-CHE-2014 POWER OF ATTORNEY 19-06-2014.pdf 2014-06-19
6 1935-CHE-2014-US(14)-ExtendedHearingNotice-(HearingDate-20-04-2022).pdf 2022-03-28
6 1935-CHE-2014 F0RM-1 19-06-2014.pdf 2014-06-19
7 1935-CHE-2014-US(14)-HearingNotice-(HearingDate-04-10-2021).pdf 2021-10-17
7 1935-CHE-2014 CORRESPONDENCE OTHERS 19-06-2014.pdf 2014-06-19
8 1935-CHE-2014-FORM-26 [04-10-2021(online)].pdf 2021-10-04
8 1935-CHE-2014-FORM 18 [04-04-2018(online)].pdf 2018-04-04
9 1935-CHE-2014-FORM 18 [04-04-2018(online)]-1.pdf 2018-04-04
9 1935-CHE-2014-Correspondence to notify the Controller [28-09-2021(online)].pdf 2021-09-28
10 1935-CHE-2014-DRAWING [30-04-2020(online)].pdf 2020-04-30
10 1935-CHE-2014-FER.pdf 2019-11-06
11 1935-CHE-2014-FER_SER_REPLY [30-04-2020(online)].pdf 2020-04-30
11 1935-CHE-2014-OTHERS [30-04-2020(online)].pdf 2020-04-30
12 1935-CHE-2014-FER_SER_REPLY [30-04-2020(online)].pdf 2020-04-30
12 1935-CHE-2014-OTHERS [30-04-2020(online)].pdf 2020-04-30
13 1935-CHE-2014-DRAWING [30-04-2020(online)].pdf 2020-04-30
13 1935-CHE-2014-FER.pdf 2019-11-06
14 1935-CHE-2014-Correspondence to notify the Controller [28-09-2021(online)].pdf 2021-09-28
14 1935-CHE-2014-FORM 18 [04-04-2018(online)]-1.pdf 2018-04-04
15 1935-CHE-2014-FORM 18 [04-04-2018(online)].pdf 2018-04-04
15 1935-CHE-2014-FORM-26 [04-10-2021(online)].pdf 2021-10-04
16 1935-CHE-2014 CORRESPONDENCE OTHERS 19-06-2014.pdf 2014-06-19
16 1935-CHE-2014-US(14)-HearingNotice-(HearingDate-04-10-2021).pdf 2021-10-17
17 1935-CHE-2014 F0RM-1 19-06-2014.pdf 2014-06-19
17 1935-CHE-2014-US(14)-ExtendedHearingNotice-(HearingDate-20-04-2022).pdf 2022-03-28
18 1935-CHE-2014 POWER OF ATTORNEY 19-06-2014.pdf 2014-06-19
18 1935-CHE-2014-FORM-26 [11-04-2022(online)].pdf 2022-04-11
19 FIGURES FOR FILING.pdf 2014-06-02
19 1935-CHE-2014-Correspondence to notify the Controller [15-04-2022(online)].pdf 2022-04-15
20 FORM 3.pdf 2014-06-02
20 1935-CHE-2014-Written submissions and relevant documents [04-05-2022(online)].pdf 2022-05-04
21 FORM 5.pdf 2014-06-02
21 1935-CHE-2014-PatentCertificate20-12-2022.pdf 2022-12-20
22 SPEC FOR FILING.pdf 2014-06-02
22 1935-CHE-2014-IntimationOfGrant20-12-2022.pdf 2022-12-20

Search Strategy

1 2019-11-0516-13-40_05-11-2019.pdf

ERegister / Renewals

3rd: 01 Mar 2023

From 11/04/2016 - To 11/04/2017

4th: 01 Mar 2023

From 11/04/2017 - To 11/04/2018

5th: 01 Mar 2023

From 11/04/2018 - To 11/04/2019

6th: 01 Mar 2023

From 11/04/2019 - To 11/04/2020

7th: 01 Mar 2023

From 11/04/2020 - To 11/04/2021

8th: 01 Mar 2023

From 11/04/2021 - To 11/04/2022

9th: 01 Mar 2023

From 11/04/2022 - To 11/04/2023

10th: 01 Mar 2023

From 11/04/2023 - To 11/04/2024

11th: 19 Mar 2024

From 11/04/2024 - To 11/04/2025

12th: 25 Mar 2025

From 11/04/2025 - To 11/04/2026